New effort probes how two groups of viruses cause disease
November 18, 2009 by Emil Venere
Purdue University is leading a team of researchers in a federally funded effort aimed ultimately at developing better vaccines and antiviral drugs against two types of disease-causing viruses. The work is led by Richard Kuhn, top left, a professor and head of the Department of Biological Sciences, Michael Rossmann, right standing, the Hanley Distinguished Professor of Biological Sciences, and Wen Jiang, an assistant professor in the Department of Biological Sciences. (Purdue University photo/Andrew Hancock)
(PhysOrg.com) -- Purdue University is leading a team of researchers in a federally funded effort aimed ultimately at developing better vaccines and antiviral drugs against two types of disease-causing viruses by learning critical details about their life cycles.
The viruses also pose a potential homeland security threat because they have been used to make biological weapons, said Richard Kuhn, a professor and head of the Department of Biological Sciences at Purdue.
"Viruses within these two groups pose significant risks to large segments of the population, and methods for controlling infection and disease are few," he said. "These are really important human diseases."
One group, called flaviviruses, includes West Nile and dengue. The other group, called alphaviruses, includes eastern equine encephalitis and chikungunya.
"Dengue infects more than 50 million people annually, killing about 24,000 each year, primarily in tropical regions," Kuhn said.
Both types of viruses are transmitted by mosquitoes and sometimes ticks.
"Although these viruses are now mostly restricted to the tropics, as population density increases in cities and there is a greater global movement of people, there is the fear that these viruses are going to gain a greater geographical range," Kuhn said. "There also is the possibility of terrorists using weapons made from these viruses, so a better understanding of their life cycles could lead to ways to defend against attacks."
The work is funded with a two-year $4 million American Recovery and Reinvestment Act grant through the National Institutes of Health's National Institute of Allergy and Infectious Diseases.
The project will involve three Purdue faculty members and two former Purdue researchers who are now at other institutions. From Purdue are Kuhn; Michael Rossmann, the Hanley Distinguished Professor of Biological Sciences; and Wen Jiang, an assistant professor in the Department of Biological Sciences. The two other researchers are Janet L. Smith, professor of life sciences and biological chemistry at the University of Michigan, and Timothy Baker, a professor in the Department of Chemistry and Biochemistry at the University of California, San Diego.
"It's a team of investigators, so instead of having five independent grants, we are working collaboratively on projects that mesh together," Kuhn said.
The work also will involve 12-15 Purdue graduate and undergraduate students, as well as postdoctoral and research scientists.
The researchers will use advanced imaging technologies, including cryoelectron microscopy and X-ray crystallography, along with techniques in biochemistry, molecular biology and genetics, to uncover critical structural details about the viruses.
Both types of viruses have a two-layer outer protein-and-lipid membrane envelope and a genome of RNA, or ribonucleic acid. In alphaviruses, the heads of key proteins protrude outward like spikes, with the tails extending into the virus. The proteins in the flaviviruses lie flat on the surface of the virus' outer shell, which resembles a golf ball's bumpy shape.
"The current understanding of alphavirus and flavivirus life cycles at the molecular level is incomplete because we lack a structural foundation for the viral and host proteins involved in RNA replication, how this genome is packaged, and how the virus is assembled inside the host cells," Kuhn said. "We are interested in their life cycles.
"What do they look like? How do they get into cells? What happens once they do? Then, how do they assemble themselves and exit the host cells?"
Researchers also will probe how antibodies bind to the viruses.
"Using structural information, we can figure out how the antibodies work and which sites they specifically bind to on the outside of the viruses, and those findings may lead to better vaccines and antiviral drugs and a better understanding of how the viruses infect host cells," Kuhn said.
A portion of the new research will be in a modern lab for virus analysis in the Wayne T. and Mary T. Hockmeyer Hall of Structural Biology, which is expected to open by the end of the year.
The lab is located on the first floor of the new $32.9 million, 65,690-square-foot Hockmeyer building, home to Purdue's Markey Center for Structural Biology research group. Hockmeyer Hall is adjacent to Discovery Park at Harrison Street and Martin Jischke Drive and is named for Wayne T. Hockmeyer and his wife, Mary, who provided $5.3 million toward its construction.
The research is an extension of previous work that began in 2002 to establish a comprehensive facility for viral structure and functional studies.
-
Findings reveal how dengue virus matures, becomes infectious
Mar 27, 2008 |
not rated yet |
0
-
Scientists learn structure of enzyme in unusual virus
Sep 17, 2007 |
not rated yet |
0
-
New research targets West Nile virus and dengue fever
Dec 11, 2008 |
not rated yet |
0
-
New West Nile and Japanese encephalitis vaccines produced
May 30, 2008 |
not rated yet |
0
-
Biologists spy close-up view of poliovirus linked to host cell receptor
Dec 08, 2008 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (30) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
Pertubance in a model
2 hours ago
-
Cancer drugs and Alzheimer's, Oh my!
10 hours ago
-
Squishing cells
11 hours ago
-
Any books/articles for evolutionary stable strategy models in humans?
22 hours ago
-
Science behind the bore feeling?
Feb 09, 2012
-
Homo Sapien vs. Chimpanzee - Divergence Timeline
Feb 09, 2012
- More from Physics Forums - Biology
More news stories
The power of estrogen -- male snakes attract other males
A new study has shown that boosting the estrogen levels of male garter snakes causes them to secrete the same pheromones that females use to attract suitors, and turned the males into just about the sexiest ...
57 minutes ago |
not rated yet |
0
|
Experts reveal how plants don't get sunburn
(PhysOrg.com) -- Experts at the University of Glasgow have discovered how plants survive the harmful rays of the sun.
44 minutes ago |
5 / 5 (1) |
0
|
New drugs schedule makes horse racing a sure thing
What do Gai Waterhouse and Anthony Cummings have in common with Queen Elizabeth II?
56 minutes ago |
not rated yet |
0
Miami battling invasion of giant African snails
No one knows how they got there. But an invasion of African giant snails has southern Florida in a panic over potential crop damage, disease and general yuckiness surrounding the slimy gastropods.
4 hours ago |
not rated yet |
2
Protein libraries in a snap
(PhysOrg.com) -- A Rice University undergraduate will depart with not only a degree but also a possible patent for his invention of an efficient way to create protein libraries, an important component of biomolecular ...
4 hours ago |
5 / 5 (1) |
0
|
Team isolates nerve cells involved in storing long term memory and gene proteins associated with them
(Medical Xpress) -- A research team in Taiwan has succeeded in isolating two nerve cells in fruit fly brains that are believed to be the major players in allowing for the formation of long term memories. Furthermore, ...
Fool's gold may prove an unlikely alternative to overexploited catalytic materials
Catalytic materials, which lower the energy barriers for chemical reactions, are used in everything from the commercial production of chemicals to catalytic converters in car engines. However, with current catalytic materials ...
SLAC, Stanford team focuses on high-energy electrons to treat cancer
Accelerator physicists at SLAC and cancer specialists from Stanford are working on a new technology that could dramatically reduce the time needed for cancer radiation treatments. The team ran an initial experiment ...
News of plaque-clearing drug tops week of major advances against Alzheimer's disease
In the last eight days, scientists have delivered a powerful one-two punch in the fight to defeat Alzheimer's disease. At the same time, the White House and members of Congress are proposing increases in Alzheimer's research ...
Unpicking HIV’s invisibility cloak
Drug researchers hunting for alternative ways to treat human immunodeficiency virus (HIV) infections may soon have a novel targetits camouflage coat. HIV hides inside a cloak unusually rich in a sugar ...
What lies beneath: Mapping hidden nanostructures
The ability to diagnose and predict the properties of materials is vital, particularly in the expanding field of nanotechnology. Electron and atom-probe microscopy can categorize atoms in thin sheets of material, ...